Purchases and Sales Made in Q4 2024 in Cardiff Oncology, Inc. (CRDF)
This table provides information about the institutional ownership of Cardiff Oncology, Inc. (CRDF) during Q4 2024. The information is specifically focused on institutions that hold shares of Cardiff Oncology, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jan 15, 2025
Q4 2024
|
Hb Wealth Management, LLC
|
BUY
|
- |
24.5KNew |
$56.6K - $131K
|
24.5K
$98.5K
|
|
|
Jan 30, 2025
Q4 2024
|
Rhumbline Advisers
Boston, MA |
BUY
|
- |
10.3K+ 24.0% |
$23.8K - $55.1K
|
53.2K
$214K
|
|
|
Jan 22, 2025
Q4 2024
|
R Squared LTD
Central, K3 |
BUY
|
- |
290New |
$670 - $1.55K
|
290
$1.17K
|
|
|
Jan 17, 2025
Q4 2024
|
Nisa Investment Advisors, LLC
|
BUY
|
- |
215+ 977.27% |
$497 - $1.15K
|
237
$953
|
|
|
Jan 29, 2025
Q4 2024
|
Gladstone Institutional Advisory LLC
Boca Raton, FL |
SELL
|
- |
-2K- 13.33% |
$4.62K - $10.7K
|
13K
$52.3K
|
|
|
Jan 17, 2025
Q4 2024
|
Sg Americas Securities, LLC
|
SELL
|
- |
-6.1K- 25.5% |
$14.1K - $32.7K
|
17.8K
$71.7K
|
|
|
Jan 14, 2025
Q4 2024
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-203K- 75.15% |
$470K - $1.09M
|
67.2K
$270K
|